183 related articles for article (PubMed ID: 34953704)
1. Tumour and normal tissue radiosensitivity.
Lapierre A; Gourgou S; Brengues M; Quéro L; Deutsch É; Milliat F; Riou O; Azria D
Cancer Radiother; 2022; 26(1-2):96-103. PubMed ID: 34953704
[TBL] [Abstract][Full Text] [Related]
2. [Predictive assays for responses of tumors and normal tissues in radiation oncology].
Riou O; Bourgier C; Brengues M; Bonnefoi N; Michaud HA; Castan F; Gourgou S; Draghici R; Farcy-Jacquet MP; Bons F; Fenoglietto P; Ozsahin M; Azria D
Cancer Radiother; 2019 Oct; 23(6-7):666-673. PubMed ID: 31451357
[TBL] [Abstract][Full Text] [Related]
3. [A genomic-adjusted radiation dose for a precision medicine in radiation oncology].
Ah-Thiane L; Supiot S; Dutreix M
Bull Cancer; 2022 Sep; 109(9):884-885. PubMed ID: 35717226
[No Abstract] [Full Text] [Related]
4. [Individual modification of the dose, volume and fractionation of breast radiotherapy].
Bourgier C; Lemanski C; Draghici R; Castan F; Fenoglietto P; Bons F; Farcy-Jacquet MP; Brengues M; Gourgou S; Ozsahin M; Azria D
Cancer Radiother; 2019 Oct; 23(6-7):778-783. PubMed ID: 31378461
[TBL] [Abstract][Full Text] [Related]
5. Radiogenomics - current status, challenges and future directions.
Andreassen CN; Schack LM; Laursen LV; Alsner J
Cancer Lett; 2016 Nov; 382(1):127-136. PubMed ID: 26828014
[TBL] [Abstract][Full Text] [Related]
6. External irradiation treatment process.
Barillot I; Azria D; Lisbona A; Mahé MA
Cancer Radiother; 2022; 26(1-2):20-28. PubMed ID: 34953717
[TBL] [Abstract][Full Text] [Related]
7. Organs at risk radiation dose constraints.
Noël G; Antoni D
Cancer Radiother; 2022; 26(1-2):59-75. PubMed ID: 34953713
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes.
Dunst J; Neubauer S; Becker A; Gebhart E
Strahlenther Onkol; 1998 Oct; 174(10):510-6. PubMed ID: 9810318
[TBL] [Abstract][Full Text] [Related]
9. Delineation of organs at risk.
Noël G; Le Fèvre C; Antoni D
Cancer Radiother; 2022; 26(1-2):76-91. PubMed ID: 34862133
[TBL] [Abstract][Full Text] [Related]
10. [Intrinsic radiosensitivity: predictive assays that will change daily practice].
Lacombe J; Riou O; Solassol J; Mangé A; Bourgier C; Fenoglietto P; Pèlegrin A; Ozsahin M; Azria D
Cancer Radiother; 2013 Oct; 17(5-6):337-43. PubMed ID: 23999252
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of radiation exposure: can they predict normal tissue radiosensitivity?
Chua ML; Rothkamm K
Clin Oncol (R Coll Radiol); 2013 Oct; 25(10):610-6. PubMed ID: 23870757
[TBL] [Abstract][Full Text] [Related]
12. [Radiosensitivity assays of normal tissues].
Lacombe J; Solassol J; Pouget JP; Coelho M; Azria D
Bull Cancer; 2011 Dec; 98(12):1469-75. PubMed ID: 22157594
[TBL] [Abstract][Full Text] [Related]
13. Prevention of radiation-induced cancers.
Chargari C; Giraud P; Lacornerie T; Cosset JM
Cancer Radiother; 2022; 26(1-2):92-95. PubMed ID: 34953687
[TBL] [Abstract][Full Text] [Related]
14. Radiogenomics: towards a personalized radiation oncology.
Roberson JD; Burnett OL; Robin N
Curr Opin Pediatr; 2016 Dec; 28(6):713-717. PubMed ID: 27552070
[TBL] [Abstract][Full Text] [Related]
15. Personalized medicine in radiation oncology and radiation sensitivity index: Pathbreaking genomic way to define the role of radiation in cancer management.
Mondal D; Pareek V; Barthwal M
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S508-S512. PubMed ID: 38384012
[TBL] [Abstract][Full Text] [Related]
16. Lung metastases radiation therapy.
Lévy A; Darréon J; Mornex F; Giraud P; Thureau S
Cancer Radiother; 2022; 26(1-2):244-249. PubMed ID: 34953714
[TBL] [Abstract][Full Text] [Related]
17. Individual Response to Ionizing Radiation and Personalized Radiotherapy.
Domina EA; Philchenkov A; Dubrovska A
Crit Rev Oncog; 2018; 23(1-2):69-92. PubMed ID: 29953368
[TBL] [Abstract][Full Text] [Related]
18. RadioTransNet: Preclinical research network coordinated at the SFRO and SFPM.
Maingon P; Marchesi V; Azria D; Balosso J; Deutsch É; Cohen Jonathan-Moyal É; Giraud P; Bayart É
Cancer Radiother; 2022; 26(1-2):108-115. PubMed ID: 34862132
[TBL] [Abstract][Full Text] [Related]
19. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer.
Barber JB; Burrill W; Spreadborough AR; Levine E; Warren C; Kiltie AE; Roberts SA; Scott D
Radiother Oncol; 2000 May; 55(2):179-86. PubMed ID: 10799730
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of radiosensitivity in normal and tumor tissue: A bioinformatic approach.
Pavlopoulou A; Bagos PG; Koutsandrea V; Georgakilas AG
Cancer Lett; 2017 Sep; 403():37-47. PubMed ID: 28619524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
